年単位の研究成果
Fingerprint Hironari Hanaokaが取り組む研究トピックをご確認ください。これらのトピックラベルは、この人物の研究に基づいています。これらを共に使用することで、固有の認識が可能になります。
- 6 同様のプロファイル
Lupus Nephritis
Medicine & Life Sciences
Kidney
Medicine & Life Sciences
Systemic Lupus Erythematosus
Medicine & Life Sciences
Hydroxychloroquine
Medicine & Life Sciences
Mycophenolic Acid
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Alveolar Soft Part Sarcoma
Medicine & Life Sciences
Signal Recognition Particle
Medicine & Life Sciences
ネットワーク
最近の共同研究。丸をクリックして詳細を確認しましょう。
研究成果 1984 2019
Adult-onset Still's disease-associated interstitial lung disease represents severe phenotype of the disease with higher rate of haemophagocytic syndrome and relapse
Takakuwa, Y., Hanaoka, H., Kiyokawa, T., Iida, H., Ishimori, K., Uekusa, T., Yamada, H. & Kawahata, K., 2019 11 1, ： : Clinical and experimental rheumatology. 37, 6, p. 23-27 5 p.研究成果: Article
Adult-Onset Still's Disease
Hemophagocytic Lymphohistiocytosis
Interstitial Lung Diseases
Phenotype
Recurrence
A low perfusion-metabolic mismatch in 99mTl and 123I-BMIPP scintigraphy predicts poor prognosis in systemic sclerosis patients with asymptomatic cardiac involvement
Iida, H., Hanaoka, H., Okada, Y., Kiyokawa, T., Takakuwa, Y., Yamada, H., Okazaki, T., Ozaki, S., Yamaguchi, K., Nakajima, Y. & Kawahata, K., 2019 1 1, ： : International Journal of Rheumatic Diseases.研究成果: Article
Systemic Scleroderma
Radionuclide Imaging
Heart Failure
Perfusion
Magnetic Resonance Imaging
Glucocorticoid, immunosuppressant, hydroxychloroquine monotherapy, or no therapy for maintenance treatment in systemic lupus erythematosus without major organ manifestations
Hanaoka, H., Iida, H., Kiyokawa, T., Takakuwa, Y. & Kawahata, K., 2019 1 1, ： : Clinical Rheumatology.研究成果: Article
Hydroxychloroquine
Immunosuppressive Agents
Systemic Lupus Erythematosus
Glucocorticoids
Prednisolone
High plasma mycophenolate acid concentration in the early phase of induction therapy predicts good renal outcome in lupus nephritis
Kiyokawa, T., Hanaoka, H., Iida, H., Ishimori, K., Takakuwa, Y., Okazaki, T., Ozaki, S. & Kawahata, K., 2019 1 1, ： : Modern Rheumatology.研究成果: Article
Mycophenolic Acid
Lupus Nephritis
Kidney
Acids
Therapeutics
Hydroxychloroquine improves the disease activity and allows the reduction of the corticosteroid dose regardless of background treatment in Japanese patients with systemic lupus erythematosus
Hanaoka, H., Iida, H., Kiyokawa, T., Takakuwa, Y. & Kawahata, K., 2019 1 1, ： : Internal Medicine. 58, 9, p. 1257-1262 6 p.研究成果: Article
公開
Hydroxychloroquine
Systemic Lupus Erythematosus
Adrenal Cortex Hormones
Prednisolone
Therapeutics